{"clarifying_information": [{"clarifying_question1": "Are you interested in the technical differences and comparative benefits of various next-generation sequencing (NGS) platforms (such as Illumina, PacBio, and Oxford Nanopore) specifically for sequencing phage display libraries, including antibody or peptide libraries?", "clarifying_answer1": {"clarifying_answer": "Yes, I am interested in the technical differences and comparative benefits of various next-generation sequencing platforms (such as Illumina, PacBio, and Oxford Nanopore) specifically for sequencing phage display libraries, including both antibody and peptide libraries."}}, {"clarifying_question2": "Would you like a focused overview on how next-generation sequencing has improved the construction and optimization of phage display libraries, including strategies to assess and maximize library diversity, randomness, and quality using NGS?", "clarifying_answer2": {"clarifying_answer": "Yes, I would like a focused overview on how next-generation sequencing has improved the construction and optimization of phage display libraries, with an emphasis on strategies for assessing and maximizing library diversity, randomness, and quality using NGS."}}, {"clarifying_question3": "Are you seeking information on specific application areas where the integration of NGS with phage display has had significant impact (e.g., antibody discovery, epitope mapping, rare binder identification), along with case study examples?", "clarifying_answer3": {"clarifying_answer": "Yes, I am interested in specific application areas where integrating NGS with phage display has made a major impact (such as antibody discovery, epitope mapping, and rare binder identification), and I would also appreciate illustrative case study examples for each application."}}], "better_queries_2": {"reformulated1": "What are the technical differences and comparative advantages of Illumina, PacBio, and Oxford Nanopore sequencing platforms for analyzing phage display libraries (including both antibody and peptide libraries), and how do these differences influence the depth, quality, and completeness of library characterization?", "reformulated2": "How has the integration of next-generation sequencing technologies improved the construction and optimization of phage display libraries, specifically in assessing and maximizing library diversity, randomness, and quality, and what strategies are commonly employed using NGS for these purposes?", "reformulated3": "Can you provide specific examples and case studies illustrating how next-generation sequencing has significantly impacted key application areas of phage display, such as antibody discovery, epitope mapping, and identification of rare binders, including the workflow and outcomes for each?"}}
